Sean Grant - Jun 15, 2021 Form 4 Insider Report for Vera Therapeutics, Inc. (VERA)

Role
Chief Financial Officer
Signature
/s/ Jodie Bourdet, Attorney-in-Fact
Stock symbol
VERA
Transactions as of
Jun 15, 2021
Transactions value $
$68,004
Form type
4
Date filed
6/16/2022, 04:06 PM
Next filing
Jul 15, 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction VERA Class A Common Stock Purchase $38.3K +2.82K $13.60 2.82K Jun 15, 2022 By IRA F1
transaction VERA Class A Common Stock Purchase $4.56K +335 $13.60 335 Jun 15, 2022 By Roth IRA F1
transaction VERA Class A Common Stock Purchase $11.7K +857 $13.60 857 Jun 15, 2022 By Spouse's IRA F1
transaction VERA Class A Common Stock Purchase $13.5K +992 $13.60 992 Jun 15, 2022 By Trust F1
holding VERA Class A Common Stock 1.52K Jun 15, 2021 Direct F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 These shares were purchased in multiple transactions for all of Reporting Person's indirect accounts on the reported date with prices ranging from $13.05 to $13.85, resulting in a weighted average price of $13.6008. Upon request, the Reporting Person will provide to Issuer, the Commission staff or a security holder of the Issuer the number of shares purchased and the purchase price for each separate transaction.
F2 Shares acquired under the Issuer's Employee Stock Purchase Plan on March 11, 2022.

Remarks:

Exhibit List: Exhibit 24 - Power of Attorney